Skip to content
10-Q

Quarterly Report

INNOVATION PHARMACEUTICALS INC.

0001477932-21-000999

← back to feed
Filed
Feb 22, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Feb 10, 2021 418.07M sh
Current Liabilities Q2 2021 · Dec 31, 2020 $6.8M
Current Liabilities Q2 2021 · Jun 30, 2020 $7.37M
Total Liabilities Q2 2021 · Dec 31, 2020 $8.97M
Total Liabilities Q2 2021 · Jun 30, 2020 $7.79M
Current Assets Q2 2021 · Dec 31, 2020 $8.28M
Current Assets Q2 2021 · Jun 30, 2020 $6.11M
Total Assets Q2 2021 · Dec 31, 2020 $12.41M
Total Assets Q2 2021 · Jun 30, 2020 $9.25M
Operating Cash Flow Q2 2021 · Dec 31, 2019 −$1.44M
Cash And Equivalents Q2 2021 · Dec 31, 2019 $187K
Cash And Equivalents Q2 2021 · Sep 30, 2019 $910K
Cash And Equivalents Q2 2021 · Jun 30, 2019 $579K
Stockholders Equity Q2 2021 · Dec 31, 2019 −$5.62M
Stockholders Equity Q2 2021 · Sep 30, 2019 −$4.54M
Stockholders Equity Q2 2021 · Jun 30, 2019 −$4.13M
Sga Expense Q2 2021 · Dec 31, 2019 $354K
Sga Expense Q2 2021 · Dec 31, 2019 $619K
Rd Expense Q2 2021 · Dec 31, 2019 $806K
Rd Expense Q2 2021 · Dec 31, 2019 $1.61M
Net Income Q2 2021 · Dec 31, 2019 −$2.63M
Net Income Q2 2021 · Dec 31, 2019 −$4.18M
Net Income Q2 2021 · Sep 30, 2019 −$1.55M
Revenue Q2 2021 · Dec 31, 2019 $0
Revenue Q2 2021 · Dec 31, 2019 $400K